Life Sciences Lunch Series: The Cost of Delayed Cancer Diagnoses

As a result of the pandemic, 2020 saw a large drop-off in the screening rates for many types of cancer. In general, cancer is easier to treat when identified in early stages and “missed” cancers may be larger or more advanced when ultimately detected. While the impact of the pandemic on overall cancer deaths will not be clear for many years, it has produced both reasons for concern and optimism.